SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001564590-23-001663 from MAIA Biotechnology, Inc. (MAIA) (CIK 0001878313) (MAIA)

MAIA Biotechnology, Inc. (MAIA) (CIK 0001878313)
Date: Feb. 9, 2023 · CIK: 0001878313 · Accession: 0001564590-23-001663

Offering / Registration Process Capital Structure Regulatory Compliance

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-269606

Date
February 9, 2023
Author
Vlad Vitoc
Form
CORRESP
Company
MAIA Biotechnology, Inc. (MAIA) (CIK 0001878313)

Letter

maia-corresp.htm

MAIA Biotechnology, Inc.

4444 West Lake Street, Suite 1700

Chicago, IL 60606

February 9, 2023

VIA EDGAR & TELECOPY

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

Washington, D.C. 20549

Attention: Jimmy McNamara

RE:

MAIA Biotechnology, Inc. (the “Company”)

Registration Statement on Form S-1 (File No. 333-269606) (the “Registration Statement”)

Withdrawal Request for Acceleration of Effective Date

Ladies and Gentlemen:

Reference is made to the Company’s letter, filed as correspondence via EDGAR on February 7, 2023, in which the Company requested acceleration of effectiveness of the Registration Statement. The Company hereby formally withdraws its request for acceleration of the effective date pursuant to the prior letter.

Very truly yours,
MAIA Biotechnology, Inc.

Show Raw Text
CORRESP
1
filename1.htm

maia-corresp.htm

MAIA Biotechnology, Inc.

4444 West Lake Street, Suite 1700

Chicago, IL 60606

February 9, 2023

VIA EDGAR & TELECOPY

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

Washington, D.C. 20549

Attention: Jimmy McNamara

RE:

MAIA Biotechnology, Inc. (the “Company”)

Registration Statement on Form S-1 (File No. 333-269606) (the “Registration Statement”)

Withdrawal Request for Acceleration of Effective Date

Ladies and Gentlemen:

Reference is made to the Company’s letter, filed as correspondence via EDGAR on February 7, 2023, in which the Company requested acceleration of effectiveness of the Registration Statement. The Company hereby formally withdraws its request for acceleration of the effective date pursuant to the prior letter.

Very truly yours,

MAIA Biotechnology, Inc.

By:

/s/ Vlad Vitoc

Name:

Vlad Vitoc

Title:

Chief Executive Officer

cc:

Angela Dowd, Esq., Loeb & Loeb LLP